The main objective of this study was to confirm skin acceptability of the product GINPI REF. GINHI BATCH: 10/06/2024 applied under normal use conditions, twice a day, in healthy female adult volunteers, under gynecological control, by means of the evaluation of organoleptic characteristics and subjective efficacy of the study product by the volunteers.

Other (secondary) objective was the assessment of unexpected adverse events referred by the volunteers as well as possible reactions observed by the investigator.

Inclusion Criteria:

• Healthy women
• Age between 18 and 65 years
• Volunteers with sensitive skin (50%) and normal skin (50%)
• Volunteers with Fitzpatrick skin photo-type I to IV
• Frequent users of similar product
• Adequate cultural level and understanding of the clinical study
• To agree to participate voluntarily in the study and grant written Informed Consent.

Exclusion Criteria:

• Volunteers with chronic or acute disease at study initiation or in the last 3 weeks prior to inclusion
• Volunteers with skin pathologies in the last 3 weeks prior to study initiation.
• Volunteers under pharmacological treatment.
• Pregnant or breast-feeding women.
• Volunteers with allergy to any of the study product components.
• Vaccinated in the last 3 weeks previous to study start.